Description
Product Description
Cabergoline was first approved for marketing in the United States in 1999, and the latest prescribing information was updated in April 2025.
Basic Information
Chinese name: Camembert
English name: Cabergoline
Common name: Cabergoline
Product specifications: 0.5mg * 8 tablets/box
Manufacturer: Lucius Pharmaceuticals
Mailing method: Hong Kong
Indications
It is indicated for the treatment of hyperprolactinemia in adults, including those with idiopathic or pituitary adenoma-related conditions.
Administration and Dosage
Please use the product according to the instructions, the pharmacist's review, or the doctor's advice; do not adjust the dosage on your own.
Important Notes
Before purchasing and using the product, please verify your personal health status and the product's scope of application; if you have underlying medical conditions, a history of allergies, or are currently taking medication, please consult a professional first.
